Renaissance Capital logo

Epocrates , Nasdaq: EPOC

Provides an ad-supported mobile drug reference app for healthcare professionals.

Industry: Technology

First Day Return: +37.3%

Provides an ad-supported mobile drug reference app for healthcare professionals.

Epocrates (EPOC) Performance

Created with Highcharts 10.3.2Chart context menuEPOC vs. IPO Index (IPOUSA)201220132014201520162017201820192020202120222023202420250%+ 500%-250%+ 250%View 5 days5dView 1 month1mView 3 months3mView year to dateYTDView 1 year1yView allAllRenaissance IPO IndexOur ETF tracks the IPO Index